ParkinsonFranceV1, Main, Exploration, bibRecordById, Pascal:95-0072068

Riluzole and experimental parkinsonism : antagonism of MPTP-induced decrease in central dopamine levels in mice

Identifieur interne : 004A75 ( Main/Exploration ); précédent : 004A74; suivant : 004A76

Riluzole and experimental parkinsonism : antagonism of MPTP-induced decrease in central dopamine levels in mice

Auteurs : A. Boireau [France] ; P. Dubedat ; F. Bordier ; C. Peny ; J.-M. Miquet ; G. Durand ; M. Meunier ; A. Doble

Source :

Neuroreport : (Oxford) [ 0959-4965 ] ; 1994.

RBID : Pascal:95-0072068

Descripteurs français

Pascal (Inist)
- Animal, Antagoniste, Corps strié, Dopamine, Libération, Neurotoxine, Parkinson maladie, Neurotoxine, Corps strié, Neurone dopaminergique, Chimiothérapie, Pathologie expérimentale, Rat, Riluzole, Récepteur glutamate, Traitement, Riluzole, Neuroprotecteur, Dopamine, Amine oxidase (flavin-containing), Animal, Souris.

English descriptors

KwdEn :
- 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (antagonists & inhibitors), 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (pharmacology), 1-Methyl-4-phenylpyridinium (antagonists & inhibitors), 3,4-Dihydroxyphenylacetic Acid (metabolism), Amine oxidase (flavin-containing), Animal, Animals, Antagonist, Brain (metabolism), Chemotherapy, Corpus Striatum (drug effects), Corpus Striatum (metabolism), Corpus striatum, Dopamine, Dopamine (metabolism), Dopaminergic neuron, Excitatory Amino Acid Antagonists, Experimental disease, Extracellular Space (metabolism), Glutamate receptor, Homovanillic Acid (metabolism), Male, Mice, Mice, Inbred C57BL, Monoamine Oxidase Inhibitors (pharmacology), Mouse, Neuroprotective agent, Neurotoxin, Parkinson Disease, Secondary (chemically induced), Parkinson Disease, Secondary (drug therapy), Parkinson disease, Rat, Rats, Release, Riluzole, Thiazoles (pharmacology), Treatment.
MESH :
- chemical , antagonists & inhibitors : 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine, 1-Methyl-4-phenylpyridinium.
- chemical , metabolism : 3,4-Dihydroxyphenylacetic Acid, Dopamine, Homovanillic Acid.
- chemical , pharmacology : 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine, Monoamine Oxidase Inhibitors, Thiazoles.
- chemically induced : Parkinson Disease, Secondary.
- drug effects : Corpus Striatum.
- drug therapy : Parkinson Disease, Secondary.
- metabolism : Brain, Corpus Striatum, Extracellular Space.
- Animals, Excitatory Amino Acid Antagonists, Male, Mice, Mice, Inbred C57BL, Rats, Riluzole.

Affiliations:

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Riluzole and experimental parkinsonism : antagonism of MPTP-induced decrease in central dopamine levels in mice</title>
<author><name sortKey="Boireau, A" sort="Boireau, A" uniqKey="Boireau A" first="A." last="Boireau">A. Boireau</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Rhône-Poulenc Rorer SA, cent. rech. Vitry-Alfortville, dép. biologie</s1>
<s2>94403 Vitry-sur-Seine</s2>
<s3>FRA</s3>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Vitry-sur-Seine</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Dubedat, P" sort="Dubedat, P" uniqKey="Dubedat P" first="P." last="Dubedat">P. Dubedat</name>
</author>
<author><name sortKey="Bordier, F" sort="Bordier, F" uniqKey="Bordier F" first="F." last="Bordier">F. Bordier</name>
</author>
<author><name sortKey="Peny, C" sort="Peny, C" uniqKey="Peny C" first="C." last="Peny">C. Peny</name>
</author>
<author><name sortKey="Miquet, J M" sort="Miquet, J M" uniqKey="Miquet J" first="J.-M." last="Miquet">J.-M. Miquet</name>
</author>
<author><name sortKey="Durand, G" sort="Durand, G" uniqKey="Durand G" first="G." last="Durand">G. Durand</name>
</author>
<author><name sortKey="Meunier, M" sort="Meunier, M" uniqKey="Meunier M" first="M." last="Meunier">M. Meunier</name>
</author>
<author><name sortKey="Doble, A" sort="Doble, A" uniqKey="Doble A" first="A." last="Doble">A. Doble</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">95-0072068</idno>
<date when="1994">1994</date>
<idno type="stanalyst">PASCAL 95-0072068 INIST</idno>
<idno type="RBID">Pascal:95-0072068</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001914</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001733</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">001787</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">001787</idno>
<idno type="wicri:doubleKey">0959-4965:1994:Boireau A:riluzole:and:experimental</idno>
<idno type="wicri:Area/Main/Merge">005431</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:95-0040742</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001920</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001727</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">001786</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">001786</idno>
<idno type="wicri:doubleKey">0959-4965:1994:Boireau A:riluzole:and:experimental</idno>
<idno type="wicri:Area/Main/Merge">005430</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:7696626</idno>
<idno type="wicri:Area/PubMed/Corpus">001654</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001654</idno>
<idno type="wicri:Area/PubMed/Curation">001613</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001613</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001613</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001613</idno>
<idno type="wicri:Area/Ncbi/Merge">001C73</idno>
<idno type="wicri:Area/Ncbi/Curation">001C73</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001C73</idno>
<idno type="wicri:doubleKey">0959-4965:1994:Boireau A:riluzole:and:experimental</idno>
<idno type="wicri:Area/Main/Merge">005242</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:7865766</idno>
<idno type="wicri:Area/PubMed/Corpus">001659</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001659</idno>
<idno type="wicri:Area/PubMed/Curation">001618</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001618</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001618</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001618</idno>
<idno type="wicri:Area/Ncbi/Merge">001C89</idno>
<idno type="wicri:Area/Ncbi/Curation">001C89</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001C89</idno>
<idno type="wicri:doubleKey">0959-4965:1994:Boireau A:riluzole:and:experimental</idno>
<idno type="wicri:Area/Main/Merge">005241</idno>
<idno type="wicri:Area/Main/Curation">004A75</idno>
<idno type="wicri:Area/Main/Exploration">004A75</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Riluzole and experimental parkinsonism : antagonism of MPTP-induced decrease in central dopamine levels in mice</title>
<author><name sortKey="Boireau, A" sort="Boireau, A" uniqKey="Boireau A" first="A." last="Boireau">A. Boireau</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Rhône-Poulenc Rorer SA, cent. rech. Vitry-Alfortville, dép. biologie</s1>
<s2>94403 Vitry-sur-Seine</s2>
<s3>FRA</s3>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Vitry-sur-Seine</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Dubedat, P" sort="Dubedat, P" uniqKey="Dubedat P" first="P." last="Dubedat">P. Dubedat</name>
</author>
<author><name sortKey="Bordier, F" sort="Bordier, F" uniqKey="Bordier F" first="F." last="Bordier">F. Bordier</name>
</author>
<author><name sortKey="Peny, C" sort="Peny, C" uniqKey="Peny C" first="C." last="Peny">C. Peny</name>
</author>
<author><name sortKey="Miquet, J M" sort="Miquet, J M" uniqKey="Miquet J" first="J.-M." last="Miquet">J.-M. Miquet</name>
</author>
<author><name sortKey="Durand, G" sort="Durand, G" uniqKey="Durand G" first="G." last="Durand">G. Durand</name>
</author>
<author><name sortKey="Meunier, M" sort="Meunier, M" uniqKey="Meunier M" first="M." last="Meunier">M. Meunier</name>
</author>
<author><name sortKey="Doble, A" sort="Doble, A" uniqKey="Doble A" first="A." last="Doble">A. Doble</name>
</author>
</analytic>
<series><title level="j" type="main">Neuroreport : (Oxford)</title>
<title level="j" type="abbreviated">Neuroreport : (Oxf.)</title>
<idno type="ISSN">0959-4965</idno>
<imprint><date when="1994">1994</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Neuroreport : (Oxford)</title>
<title level="j" type="abbreviated">Neuroreport : (Oxf.)</title>
<idno type="ISSN">0959-4965</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (antagonists & inhibitors)</term>
<term>1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (pharmacology)</term>
<term>1-Methyl-4-phenylpyridinium (antagonists & inhibitors)</term>
<term>3,4-Dihydroxyphenylacetic Acid (metabolism)</term>
<term>Amine oxidase (flavin-containing)</term>
<term>Animal</term>
<term>Animals</term>
<term>Antagonist</term>
<term>Brain (metabolism)</term>
<term>Chemotherapy</term>
<term>Corpus Striatum (drug effects)</term>
<term>Corpus Striatum (metabolism)</term>
<term>Corpus striatum</term>
<term>Dopamine</term>
<term>Dopamine (metabolism)</term>
<term>Dopaminergic neuron</term>
<term>Excitatory Amino Acid Antagonists</term>
<term>Experimental disease</term>
<term>Extracellular Space (metabolism)</term>
<term>Glutamate receptor</term>
<term>Homovanillic Acid (metabolism)</term>
<term>Male</term>
<term>Mice</term>
<term>Mice, Inbred C57BL</term>
<term>Monoamine Oxidase Inhibitors (pharmacology)</term>
<term>Mouse</term>
<term>Neuroprotective agent</term>
<term>Neurotoxin</term>
<term>Parkinson Disease, Secondary (chemically induced)</term>
<term>Parkinson Disease, Secondary (drug therapy)</term>
<term>Parkinson disease</term>
<term>Rat</term>
<term>Rats</term>
<term>Release</term>
<term>Riluzole</term>
<term>Thiazoles (pharmacology)</term>
<term>Treatment</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en"><term>1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine</term>
<term>1-Methyl-4-phenylpyridinium</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>3,4-Dihydroxyphenylacetic Acid</term>
<term>Dopamine</term>
<term>Homovanillic Acid</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine</term>
<term>Monoamine Oxidase Inhibitors</term>
<term>Thiazoles</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Parkinson Disease, Secondary</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Corpus Striatum</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease, Secondary</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Brain</term>
<term>Corpus Striatum</term>
<term>Extracellular Space</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Excitatory Amino Acid Antagonists</term>
<term>Male</term>
<term>Mice</term>
<term>Mice, Inbred C57BL</term>
<term>Rats</term>
<term>Riluzole</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Animal</term>
<term>Antagoniste</term>
<term>Corps strié</term>
<term>Dopamine</term>
<term>Libération</term>
<term>Neurotoxine</term>
<term>Parkinson maladie</term>
<term>Neurotoxine</term>
<term>Corps strié</term>
<term>Neurone dopaminergique</term>
<term>Chimiothérapie</term>
<term>Pathologie expérimentale</term>
<term>Rat</term>
<term>Riluzole</term>
<term>Récepteur glutamate</term>
<term>Traitement</term>
<term>Riluzole</term>
<term>Neuroprotecteur</term>
<term>Dopamine</term>
<term>Amine oxidase (flavin-containing)</term>
<term>Animal</term>
<term>Souris</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list><country><li>France</li>
</country>
<region><li>Île-de-France</li>
</region>
<settlement><li>Vitry-sur-Seine</li>
</settlement>
</list>
<tree><noCountry><name sortKey="Bordier, F" sort="Bordier, F" uniqKey="Bordier F" first="F." last="Bordier">F. Bordier</name>
<name sortKey="Doble, A" sort="Doble, A" uniqKey="Doble A" first="A." last="Doble">A. Doble</name>
<name sortKey="Dubedat, P" sort="Dubedat, P" uniqKey="Dubedat P" first="P." last="Dubedat">P. Dubedat</name>
<name sortKey="Durand, G" sort="Durand, G" uniqKey="Durand G" first="G." last="Durand">G. Durand</name>
<name sortKey="Meunier, M" sort="Meunier, M" uniqKey="Meunier M" first="M." last="Meunier">M. Meunier</name>
<name sortKey="Miquet, J M" sort="Miquet, J M" uniqKey="Miquet J" first="J.-M." last="Miquet">J.-M. Miquet</name>
<name sortKey="Peny, C" sort="Peny, C" uniqKey="Peny C" first="C." last="Peny">C. Peny</name>
</noCountry>
<country name="France"><region name="Île-de-France"><name sortKey="Boireau, A" sort="Boireau, A" uniqKey="Boireau A" first="A." last="Boireau">A. Boireau</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004A75 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004A75 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:95-0072068
   |texte=   Riluzole and experimental parkinsonism : antagonism of MPTP-induced decrease in central dopamine levels in mice
}}

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024

La maladie de Parkinson en France (serveur d'exploration)

Riluzole and experimental parkinsonism : antagonism of MPTP-induced decrease in central dopamine levels in mice

Riluzole and experimental parkinsonism : antagonism of MPTP-induced decrease in central dopamine levels in mice

Source :

Descripteurs français

English descriptors

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	La maladie de Parkinson en France (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.